How Is A Meld Score Calculated

Calculate your Model for End-Stage Liver Disease (MELD) score to assess liver transplant urgency

Comprehensive Guide: How Is a MELD Score Calculated?

The Model for End-Stage Liver Disease (MELD) score is a numerical scale ranging from 6 to 40 that measures the severity of chronic liver disease. Developed in 2000 and adopted by UNOS (United Network for Organ Sharing) in 2002, the MELD score determines liver transplant allocation priority in the United States.

MELD Score Formula

The original MELD score is calculated using three laboratory values:

1. Bilirubin (mg/dL) – measures liver’s ability to excrete bile
2. INR (International Normalized Ratio) – measures blood clotting ability
3. Creatinine (mg/dL) – measures kidney function

The exact formula is:

MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43

MELD-Na Score (Updated Version)

In 2016, UNOS implemented the MELD-Na score which incorporates sodium levels to improve accuracy:

MELD-Na = MELD + 1.32×(137 – Na) – [0.033×MELD×(137 – Na)]

Where Na is serum sodium concentration (mEq/L) with minimum value of 125 and maximum of 137.

Special Considerations in MELD Calculation

Creatinine Adjustments

• Minimum creatinine value: 1.0 mg/dL
• Maximum creatinine value: 4.0 mg/dL
• Patients on dialysis twice in the past week: creatinine automatically set to 4.0 mg/dL

Bilirubin Adjustments

• Minimum bilirubin value: 1.0 mg/dL
• Maximum bilirubin value: no upper limit

MELD Score Interpretation

MELD Score Range	3-Month Mortality Risk	Transplant Priority
< 9	1.9%	Low priority
10-19	6.0%	Moderate priority
20-29	19.6%	High priority
30-39	52.6%	Highest priority
≥ 40	71.3%	Emergency priority

Clinical Applications of MELD Score

1. Liver Transplant Allocation: The primary use of MELD score is to prioritize candidates for liver transplantation. Higher scores indicate greater urgency.
2. Prognosis Prediction: MELD score helps predict 3-month mortality risk in patients with cirrhosis and portal hypertension.
3. Treatment Decision Making: Clinicians use MELD scores to determine appropriate interventions and timing for procedures.
4. Clinical Trial Eligibility: Many liver disease studies use MELD score thresholds for patient inclusion.

Limitations of MELD Score

Underestimates Severity In:

• Hepatocellular carcinoma patients
• Patients with hepatic encephalopathy
• Patients with ascites

Overestimates Severity In:

• Patients with acute kidney injury
• Patients on certain medications affecting INR

MELD Score vs. Other Liver Disease Scoring Systems

Scoring System	Parameters	Primary Use	Advantages	Limitations
MELD	Bilirubin, INR, Creatinine	Transplant allocation	Objective, lab-based, dynamic	Doesn’t account for ascites, encephalopathy
Child-Pugh	Bilirubin, Albumin, INR, Ascites, Encephalopathy	Prognosis in cirrhosis	Includes clinical parameters	Subjective components, less precise
UKELD	Bilirubin, INR, Creatinine, Sodium, Age	UK transplant allocation	Includes sodium and age	Less validated in US populations

Frequently Asked Questions About MELD Score

How often is MELD score updated?

MELD scores are automatically updated in the UNOS system every 7 days for waitlisted patients, using the most recent lab values available in the system.

Can MELD score decrease over time?

Yes, with appropriate treatment and improvement in liver function, a patient’s MELD score can decrease. This might affect their position on the transplant waiting list.

What’s the highest MELD score possible?

The theoretical maximum MELD score is 40. Patients with scores ≥ 40 have a 71.3% risk of mortality within 3 months without a transplant.

Expert Insights on MELD Score

According to research published in the National Library of Medicine, the MELD score has significantly improved organ allocation efficiency since its implementation. The study found that:

• Waitlist mortality decreased by 12% in the first year after MELD implementation
• Transplant rates for the sickest patients (MELD ≥ 25) increased by 50%
• The median MELD score at transplant increased from 18 to 24, indicating better allocation to sicker patients

The Organ Procurement and Transplantation Network (OPTN) provides official policies and calculations for MELD scores used in U.S. transplant allocation. Their data shows that as of 2023:

• Over 11,000 liver transplants are performed annually in the U.S.
• The median MELD score at transplant is 28
• Patients with MELD scores ≥ 35 receive priority allocation for high-quality organs

Future Directions in Liver Allocation

Researchers are continuously working to improve liver allocation systems. Some potential future developments include:

1. Incorporating additional biomarkers: Adding markers like lactate, ammonia, or hepatic venous pressure gradient to improve accuracy.
2. Dynamic scoring systems: Real-time monitoring of physiological parameters to create more responsive scoring.
3. AI-enhanced prediction models: Machine learning algorithms that can integrate more complex patient data.
4. Regional variations: Adjusting scoring systems based on geographic differences in disease prevalence and donor availability.

For the most current information on MELD score calculations and liver transplant policies, patients and healthcare providers should consult the official UNOS website.